author-photo

Ayse Salihoglu

Istanbul University

84

Papers

312

Citations

Citation Trend

Filter By

Papers (54) Sort By

Journal Conference Others

Treatment Responses, Toxicity and Survival in Patients with Classical Hodgkin Lymphoma Aged 50 Years and Older: A Single-Center Experience over 2 Decades

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
The Impact of the COVID-19 Pandemic on the Diagnosis and Management of Patients with Classical Hodgkin Lymphoma: A Single-Center Experience

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of imatinib treatment in elderly patients with chronic myeloid leukemia: Real-life data and a single-center experience

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (2)
P-125: An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Genetic Features and TP53 Mutations in Chronic Lymphocytic Leukemia

2021
Show All
- Source
- Cite
- Save
Citations (0)
An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date.

2021 Drug Design Development and Therapy
Show All
- Source
- Cite
- Save
Citations (0)
The prognostic value of a proliferation-inducing ligand (APRIL) serum levels in treatment-naive patients with chronic lymphocytic leukemia.

2020 Turkish Journal of Medical Sciences
Show All
- Source
- Cite
- Save
Citations (0)
An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality.

2020 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (4)
Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country.

2020 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (2)
Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience

2020 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (0)